关注
Sandra Elaine Dunn
Sandra Elaine Dunn
Founder and CEO, Phoenix Molecular Diagnostics
在 phoenixmd.ca 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
P Buczkowicz, C Hoeman, P Rakopoulos, S Pajovic, L Letourneau, ...
Nature genetics 46 (5), 451-456, 2014
6302014
Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice
SE Dunn, FW Kari, J French, JR Leininger, G Travlos, R Wilson, JC Barrett
Cancer research 57 (21), 4667-4672, 1997
5471997
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival
JH Law, G Habibi, K Hu, H Masoudi, MYC Wang, AL Stratford, E Park, ...
Cancer research 68 (24), 10238-10246, 2008
4672008
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
V Ramaswamy, M Remke, E Bouffet, CC Faria, S Perreault, YJ Cho, ...
The lancet oncology 14 (12), 1200-1207, 2013
4062013
A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer
SE Dunn, M Ehrlich, NJH Sharp, K Reiss, G Solomon, R Hawkins, ...
Cancer research 58 (15), 3353-3361, 1998
3761998
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells
BW Sutherland, J Kucab, J Wu, C Lee, MCU Cheang, E Yorida, D Turbin, ...
Oncogene 24 (26), 4281-4292, 2005
3682005
Divergent clonal selection dominates medulloblastoma at recurrence
AS Morrissy, L Garzia, DJH Shih, S Zuyderduyn, X Huang, P Skowron, ...
Nature 529 (7586), 351-357, 2016
3482016
FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
NH Badve S1, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S ...
Clin Cancer Res. 13 (15 Pt 1), 4415-21, 2007
3192007
Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs
SE Dunn, RA Hardman, FW Kari, JC Barrett
Cancer research 57 (13), 2687-2693, 1997
2981997
Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors
D Faury, A Nantel, SE Dunn, MC Guiot, T Haque, P Hauser, M Garami, ...
Journal of Clinical Oncology 25 (10), 1196-1208, 2007
2722007
Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma
NA Makretsov, DG Huntsman, TO Nielsen, E Yorida, M Peacock, ...
Clinical cancer research 10 (18), 6143-6151, 2004
2442004
YB-1: oncoprotein, prognostic marker and therapeutic target?
BAW Lasham A1, Print CG, Woolley AG, Dunn SE
Biochem J. 449 (1), 11-23, 2013
2332013
Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2
J Wu, C Lee, D Yokom, H Jiang, MCU Cheang, E Yorida, D Turbin, ...
Cancer research 66 (9), 4872-4879, 2006
2112006
Y-Box Binding Protein-1 Induces the Expression of CD44 and CD49f Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance
K To, A Fotovati, KM Reipas, JH Law, K Hu, J Wang, A Astanehe, ...
Cancer research 70 (7), 2840-2851, 2010
2072010
Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer …
AL Stratford, G Habibi, A Astanehe, H Jiang, K Hu, E Park, A Shadeo, ...
Breast cancer research 9, 1-14, 2007
1852007
Identification of ROCK1 kinase as a critical regulator of Beclin1-mediated autophagy during metabolic stress
AU Gurkar, K Chu, L Raj, R Bouley, SH Lee, YB Kim, SE Dunn, ...
Nature communications 4 (1), 1-13, 2013
1762013
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
AL Stratford, CJ Fry, C Desilets, AH Davies, YY Cho, Y Li, Z Dong, ...
Breast Cancer Research 10, 1-12, 2008
1702008
Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival
AA Troussard, PC McDonald, ED Wederell, NM Mawji, NR Filipenko, ...
Cancer research 66 (1), 393-403, 2006
1662006
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
G Habibi, S Leung, JH Law, K Gelmon, H Masoudi, D Turbin, M Pollak, ...
Breast Cancer Research 10, 1-9, 2008
1572008
Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide
J Triscott, C Lee, K Hu, A Fotovati, R Berns, M Pambid, M Luk, RE Kast, ...
Oncotarget 3 (10), 1112, 2012
1522012
系统目前无法执行此操作,请稍后再试。
文章 1–20